Records containing: Parkinson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-02-23Subthalamic Nuclei (STN) Local Field Potentials to Investigate Motor Control During REM Sleep Behaviour Disorder (TCSP) Secondary to Idiopathic Parkinsons Disease (PD)
-
CLINICAL_TRIALS study record update · 2017-02-23Effect of Levodopa on Postural Motor Learning in Parkinson Disease
-
CLINICAL_TRIALS study record update · 2017-02-15Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-02-14To Rehabilitate With Virtual Reality: To Evaluate the Effect of Virtual Reality on Cardiocirculatory System and on Balance in a Sample of Healthy Subject and Patients Affected by Parkinson Disease
-
CLINICAL_TRIALS study record update · 2017-02-08A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of a Range of SCH 420814 Doses in Subjects With Moderate to Severe Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesias
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-02-07Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
-
CLINICAL_TRIALS study record update · 2017-02-02A Computerized Cognitive Behavioral Therapy Randomized, Controlled, Pilot Trial for Insomnia in Parkinson Disease (The ACCORD-PD Study)
-
CLINICAL_TRIALS study record update · 2017-02-02Cognitive Phenotypes in Parkinson's Disease: Anatomical and Functional Correlates
-
CLINICAL_TRIALS study record update · 2017-01-27Using Technology to Deliver Multi-disciplinary Care to Individuals With Parkinson Disease in Their Homes: the Connect.Parkinson Study
-
CLINICAL_TRIALS study record update · 2017-01-25Behavioural Addiction and Genetics in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-01-24Effect of Visuospatial Training Tasks on Freezing of Gait in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2017-01-18A Two Year Phase IIIb Randomised, Multicenter, Double-blind, SINEMET Controlled, Parallel Group, Flexible Dose Study, to Assess the Effectiveness of Controlled Release Ropinirole add-on Therapy to L-dopa at Increasing the Time to Onset of Dyskinesia in Parkinson's Disease Subjects.
-
CLINICAL_TRIALS study record update · 2017-01-09Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease
-
CLINICAL_TRIALS study record update · 2017-01-06Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions
-
CLINICAL_TRIALS study record update · 2017-01-06Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease, Huntington Disease, and Healthy Controls
-
CLINICAL_TRIALS study record update · 2016-12-16Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
-
CLINICAL_TRIALS study record update · 2016-12-12A Phase 3, 40-Week, Active-Controlled, Double-Blind, Double-Dummy Extension Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Phase 3, Protocol No. P06153)
-
CLINICAL_TRIALS study record update · 2016-12-08Understand Freezing of Gait in Parkinson's Disease: Behavioral Physiology and Clinical Application
-
CLINICAL_TRIALS study record update · 2016-12-06A Phase 2, 36-Week, Open-Label, Uncontrolled Safety Follow-up Study Assessing SCH 420814 (Preladenant) 5 mg BID (P05175)
-
CLINICAL_TRIALS study record update · 2016-12-05Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm
-
CLINICAL_TRIALS study record update · 2016-11-28Effects of a Speech-Language Pathology Intervention on Individuals With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2016-11-28Effect of Body Suspension and Tilting Exercises in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2016-11-22Investigating the Effect of Specific, Long- Term, Community-based Exercises on Walking, Balance, and Quality of Life in Adults With Parkinson Disease.
-
CLINICAL_TRIALS study record update · 2016-11-17Effects of Progressive Resistance Exercise in Akinetic-rigid Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2016-10-31A Randomized, Placebo-controlled, Parallel Group, Patient-blinded, Multi-center, Phase I Pilot Study to Assess Tolerability and Safety of Two Doses of AFFITOPE® PD03A Formulated With Adjuvant to Patients With Early Parkinson's Disease